Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination.

Homero Contreras-SalinasMariana Barajas-HernándezLeopoldo Martín Baiza-DuránAlan Omar Vázquez-ÁlvarezManuel Alejandro Bautista-CastroLourdes Yolotzin Rodríguez-Herrera

Published in: Clinical ophthalmology (Auckland, N.Z.) (2021)

Three safety signals were identified, two of them corresponded to an increase in the incidence of ADRs and the last one is associated with 2 unexpected ADR. Nevertheless, we found a good tolerability profile for TBD in the study population.

Keyphrases

adverse drug
public health
risk factors
open label
randomized controlled trial
emergency department
double blind
placebo controlled
study protocol